Chemical formula: C₁₉H₂₀Br₂N₆O₄S Molecular mass: 588.273 g/mol PubChem compound: 16004692
Macitentan is indicated for:
Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)
Macitentan, as monotherapy or in combination, is indicated for the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients and in paediatric patients aged less than 18 years and bodyweight ≥40 kg with of WHO Functional Class (FC) II to III).
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Macitentan is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.